bf/NASDAQ:AUTL_icon.jpeg

COM:AUTOLUS

Autolus Therapeutics plc

  • Stock

USD

Last Close

2.84

22/11 21:00

Market Cap

1.05B

Beta: -

Volume Today

1.60M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '16
Sep '17
Sep '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.10M
-
5.01M
353.71%
-10.94M
318.36%
-9.78M
10.58%
12.14M
224.12%
average payables
1.69M
-
7.23M
327.40%
6.80M
6.02%
1.67M
75.44%
1.35M
19.29%
481K
64.29%
average receivables
3.46M
-
5.77M
67.00%
18.67M
223.52%
30.10M
61.28%
27.97M
7.10%
27.61M
1.27%
book value per share
2.23
-
10.35
364.70%
6.50
37.17%
5.92
8.97%
4.07
31.16%
4.35
6.70%
3.14
27.66%
capex per share
-0.13
-
-0.21
55.04%
-0.28
33.21%
-0.43
55.95%
-0.28
34.31%
-0.12
56.85%
-0.11
7.12%
capex to depreciation
-3.88
-
-2.85
26.55%
-7.94
178.49%
-4.05
49.00%
-2.59
35.91%
-1.05
59.64%
-1.46
39.49%
capex to operating cash flow
0.19
-
0.18
6.66%
0.34
93.04%
0.18
45.79%
0.12
32.23%
0.08
39.72%
0.10
28.45%
capex to revenue
-1.53
-
-1.70
10.99%
-8.39
393.94%
-6.42
23.49%
-60.67
845.01%
-3.80
93.73%
-1.75
53.96%
cash per share
2.04
-
9.94
388.51%
6.00
39.68%
4.89
18.46%
2.97
39.21%
4.31
44.79%
4.03
6.49%
days of inventory on hand
-2.23K
-
days payables outstanding
-12.63K
-
days sales outstanding
656.22
-
1.02K
55.43%
2.38K
133.08%
3.83K
61.16%
44.77K
1,068.62%
4.11K
90.82%
1.71K
58.48%
debt to assets
0.01
-
0.00
67.59%
0.00
43.04%
0.09
8,407.91%
0.18
113.08%
0.05
71.87%
0.05
4.44%
debt to equity
0.01
-
0.00
69.67%
0.00
42.03%
0.10
9,450.81%
0.26
150.62%
0.07
74.01%
0.08
21.18%
dividend yield
earnings yield
-0.04
-
-0.06
57.19%
-0.03
43.79%
-0.22
577.03%
-0.31
41.50%
-0.38
23.21%
-0.82
117.12%
-0.19
77.44%
enterprise value
316.71M
-
207.78M
34.40%
777.83M
274.36%
384.04M
50.63%
361.79M
5.79%
84.78M
76.57%
-177.69M
309.60%
enterprise value over ebitda
-22.79
-
-9.27
59.31%
-22.09
138.26%
-2.88
86.95%
-2.23
22.75%
-0.54
75.55%
1.14
308.78%
ev to operating cash flow
-32.16
-
-12.70
60.50%
-30.09
136.95%
-3.78
87.42%
-3.07
18.81%
-0.72
76.59%
1.58
319.97%
ev to sales
261.31
-
122.73
53.03%
744.09
506.30%
132.06
82.25%
1.50K
1,032.03%
36.38
97.57%
-28.69
178.85%
free cash flow per share
-0.85
-
-1.40
64.35%
-1.10
21.39%
-2.79
154.32%
-2.57
7.93%
-1.76
31.56%
-1.30
26.25%
free cash flow yield
-0.03
-
-0.06
64.35%
-0.04
35.86%
-0.21
490.34%
-0.29
35.94%
-0.34
17.88%
-0.68
101.44%
graham net net
1.90
-
9.76
413.57%
5.80
40.60%
4.38
24.42%
1.48
66.14%
3.37
127.01%
2.31
31.37%
graham number
6.75
-
18.25
170.27%
12.01
34.21%
19.57
62.94%
15.89
18.78%
13.88
12.64%
10.53
24.17%
income quality
0.78
-
0.83
5.68%
0.83
0.17%
0.82
1.36%
0.83
1.14%
0.83
0.09%
0.75
9.03%
intangibles to total assets
0
-
0
0.04
Infinity%
0.00
98.04%
0.00
35.83%
0.00
70.15%
0
100%
0
interest coverage
293.39
-
616.26
110.05%
-4.54K
837.02%
-148.60
-
-18.39
87.62%
interest debt per share
0.01
-
0.02
63.31%
0.01
55.04%
0.61
8,122.77%
1.05
72.53%
0.31
70.81%
0.35
13.85%
inventory turnover
-0.16
-
invested capital
0.01
-
0.00
69.67%
0.00
42.03%
0.10
9,450.81%
0.26
150.62%
0.07
74.01%
0.08
21.18%
market cap
344.58M
-
344.58M
0%
966.91M
180.60%
568.47M
41.21%
460.93M
18.92%
374.12M
18.83%
180.49M
51.76%
1.12B
520.64%
net current asset value
27.43M
-
136.42M
397.29%
186.63M
36.80%
200.56M
7.47%
112.78M
43.77%
254.71M
125.85%
234.17M
8.06%
net debt to ebitda
2.01
-
6.10
204.42%
5.37
12.04%
1.38
74.23%
0.61
55.92%
1.86
204.48%
2.29
23.31%
net income per share
-0.91
-
-1.43
57.19%
-0.99
31.11%
-2.88
191.67%
-2.76
4.17%
-1.97
28.47%
-1.57
20.52%
-1.20
23.54%
operating cash flow per share
-0.71
-
-1.19
66.11%
-0.82
30.99%
-2.36
187.71%
-2.28
3.08%
-1.64
28.41%
-1.18
27.69%
payables turnover
-0.03
-
receivables turnover
0.56
-
0.36
35.66%
0.15
57.10%
0.10
37.95%
0.01
91.44%
0.09
988.80%
0.21
140.83%
research and ddevelopement to revenue
8.61
-
9.46
9.84%
23.57
149.20%
36.25
53.81%
557.39
1,437.58%
57.85
89.62%
22.92
60.37%
76.84
235.21%
return on tangible assets
-0.37
-
-0.13
63.86%
-0.15
12.53%
-0.41
173.47%
-0.48
18.32%
-0.35
27.48%
-0.30
13.37%
revenue per share
0.09
-
0.12
39.69%
0.03
73.03%
0.07
103.85%
0.00
93.05%
0.03
588.65%
0.07
101.73%
0.01
85.03%
roe
-0.41
-
-0.14
66.17%
-0.15
9.64%
-0.49
220.42%
-0.68
39.21%
-0.45
32.96%
-0.50
9.88%
roic
-0.41
-
-0.14
66.09%
-0.24
73.31%
-0.40
66.76%
-0.45
12.93%
-0.40
12.36%
-0.41
2.47%
sales general and administrative to revenue
4.25
-
5.37
26.43%
16.12
199.84%
13.57
15.81%
144.51
965.20%
13.68
90.54%
5.15
62.34%
shareholders equity per share
2.23
-
10.35
364.70%
6.50
37.17%
5.92
8.97%
4.07
31.16%
4.35
6.70%
3.14
27.66%
stock based compensation to revenue
1.86
-
1.86
0.01%
4.81
158.20%
10.39
116.05%
83.09
699.74%
4.26
94.87%
1.94
54.52%
tangible asset value
30.69M
-
142.60M
364.70%
195.84M
37.34%
254.59M
29.99%
209.87M
17.56%
313.25M
49.26%
298.67M
4.65%
tangible book value per share
2.23
-
10.35
364.70%
6.21
40.01%
5.91
4.74%
4.07
31.14%
4.35
6.76%
3.14
27.65%
working capital
28.19M
-
137.45M
387.56%
186.63M
35.78%
224.27M
20.17%
163.35M
27.16%
318.40M
94.92%
379.40M
19.16%

All numbers in USD (except ratios and percentages)